Cipher Pharmaceuticals IncTSX:CPHView on OTCQX International
- LAST PRICE8.8200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots8.8100/ 2
- Ask / Lots9.0000/ 7
- Open / Previous Close8.8500 / 8.8200
- Day Range
- 52 Week Range
- Volume6,227
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CPH |
|---|---|---|
| 09:32 ET | 100 | 8.85 |
| 09:52 ET | 100 | 8.85 |
| 09:56 ET | 500 | 8.84 |
| 10:46 ET | 100 | 8.84 |
| 10:57 ET | 600 | 8.84 |
| 11:31 ET | 600 | 8.79 |
| 11:38 ET | 700 | 8.73 |
| 11:49 ET | 200 | 8.79 |
| 12:03 ET | 700 | 8.78 |
| 12:21 ET | 700 | 8.75 |
| 12:30 ET | 200 | 8.8 |
| 01:24 ET | 100 | 8.81 |
| 03:21 ET | 100 | 8.85 |
| 03:30 ET | 900 | 8.85 |
| 03:59 ET | 300 | 8.82 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cipher Pharmaceuticals Inc | 214.4M | 8.0x | +78.01% |
1CM Inc | 141.3M | -82.8x | --- |
Innocan Pharma Corp | 83.0M | -11.5x | --- |
Spectral Medical Inc | 124.4M | -7.9x | --- |
Biosyent Inc | 101.2M | 16.1x | +6.22% |
BellRock Brands Inc | 48.9M | -0.6x | --- |
Company Information
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.
Contact Information
- Headquarters
- 5750 Explorer Drive,, Suite 404MISSISSAUGA, ON, Canada L4W 0A9
- Phone
- 905-602-5840
- Fax
- 905-602-5840
Executives
- Independent Director
- Craig Mull
- Chief Financial Officer
- Bryan Jacobs
- Vice President - Scientific and Medical Affairs
- Diane Gajewczyk
- Director
- Arthur Deboeck
- Independent Director
- Christian Godin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $214.4M |
|---|---|
Revenue (TTM) | $29.3M |
Shares Outstanding | 24.0M |
Cipher Pharmaceuticals Inc does not pay a dividend. | |
Beta | 1.04 |
EPS | $1.10 |
Book Value | $4.64 |
P/E Ratio | 8.0x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 7.2x |
Operating Margin | 47.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
